Tetratherix Limited (ASX:TTX)
Australia
· Delayed Price · Currency is AUD 4.700
0.00 (0.00%)
Apr 29, 2026, 9:59 AM AEST
Tetratherix Market Cap
Tetratherix has a market cap or net worth of 238.60 million as of April 28, 2026.
Market Cap
238.60M
Enterprise Value
228.24M
Revenue
2.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.70
Market Cap Chart
Since June 30, 2025, Tetratherix's market cap has increased from 152.00M to 238.60M, an increase of 56.97%. That is a compound annual growth rate of 72.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 238.60M | 44.53% |
| Dec 30, 2025 | 165.09M | 8.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orthocell | 236.04M |
| Dimerix | 228.15M |
| Starpharma Holdings | 303.23M |
| Actinogen Medical | 158.03M |
| Recce Pharmaceuticals | 153.27M |
| Clinuvel Pharmaceuticals | 455.87M |
| Racura Oncology | 517.08M |
| Island Pharmaceuticals | 110.84M |